China Reinsurance Group Corporation is a prominent entity within the reinsurance industry, providing essential risk management solutions. As a reinsurance company, its primary function is to offer insurance to insurance companies, allowing them to spread risk more efficiently. This risk transfer helps ensure stability and confidence in the broader insurance market. China Reinsurance Group has a diverse portfolio, encompassing areas such as property and casualty reinsurance, life and health reinsurance, and asset management. It operates primarily in China but has a growing international presence, reflecting its influence in both domestic and global markets. The company plays a crucial role in supporting insurance firms to manage large-scale risks, including those associated with natural catastrophes and large-scale industrial projects. Established to strengthen China's national insurance capabilities, China Reinsurance Group continues to contribute significantly to the country's economic resilience and development.
Industry
Insurance Reinsurance
Financial Services sector · China
Stories
Structural patterns identified in China Reinsurance Group Corporation
No stories identified yet.
Key Metrics
Market Capitalization
67.97BHKD
NormalMar 18, 2026
Trailing P/E
5.42HKD
NormalMar 18, 2026
Revenue (TTM)
117.20BHKD
NormalMar 18, 2026
Forward Yield
12.45%
Above 5Y avg (5.75%)
Annual Rate
HKD 0.22
Paid annual
Payout Ratio
18.5%
Sustainable
Loading dividend history...
Track Record
Frequency
Annual
Upcoming
Ex-Dividend Date
Jul 7, 2025
Valuation9
Market Capitalization
67.97BHKD
NormalMar 18, 2026
Enterprise Value
18.11BHKD
NormalMar 18, 2026
Trailing P/E
5.42HKD
Coordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination
Profit Margin
10.73%
Normal
Mar 18, 2026
Beta
0.8740HKD
NormalMar 18, 2026
52-Week Change
34.66HKD
ExtremeMar 18, 2026
Forward Annual Dividend Yield
12.45%
AboveNormalMar 18, 2026
Normal
Mar 18, 2026
Forward P/E
5.52HKD
NormalMar 18, 2026
PEG Ratio
5.52HKD
AboveNormalMar 18, 2026
Price to Sales (TTM)
0.6912HKD
NormalMar 18, 2026
Price to Book (MRQ)
0.5869HKD
NormalMar 18, 2026
Enterprise to Revenue
0.1550HKD
NormalMar 18, 2026
Enterprise to EBITDA
1.08HKD
NormalMar 18, 2026
Profitability & Growth49
Profit Margin
10.73%
NormalMar 18, 2026
Operating Margin
13.93%
NormalMar 18, 2026
Return on Assets (TTM)
0.0179HKD
NormalMar 18, 2026
Return on Equity (TTM)
0.1048HKD
NormalMar 18, 2026
Revenue (TTM)
117.20BHKD
NormalMar 18, 2026
Revenue per Share (TTM)
2.43HKD
NormalMar 18, 2026
Quarterly Revenue Growth
-0.0080HKD
NormalMar 18, 2026
Gross Profit (TTM)
20.23BHKD
NormalMar 18, 2026
EBITDA
16.77BHKD
ExtremeMar 18, 2026
Net Income (TTM)
12.57BHKD
NormalMar 18, 2026
Quarterly Earnings Growth (YoY)
0.0900HKD
NormalMar 18, 2026
Operating Cash Flow (TTM)
17.53BHKD
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
-8.98BHKD
NormalMar 18, 2026
Forward Annual Dividend Rate
0.2191HKD
NormalMar 18, 2026
Forward Annual Dividend Yield
12.45%
AboveNormalMar 18, 2026
Trailing Annual Dividend Rate
0.0548HKD
NormalMar 18, 2026
Trailing Annual Dividend Yield
3.11%
NormalMar 18, 2026
5-Year Average Dividend Yield
575.00%
ExtremeMar 18, 2026
Payout Ratio
0.1854HKD
NormalMar 18, 2026
Minority Interest (Equity)
9.41B
NormalFY2024 · Dec 31, 2024
Revenue
85.54B
NormalFY2024 · Dec 31, 2024
Pre-tax Income
13.80B
NormalFY2024 · Dec 31, 2024
Income Tax Expense
2.72B
NormalFY2024 · Dec 31, 2024
Net Income
11.08B
NormalFY2024 · Dec 31, 2024
EBIT
15.81B
NormalFY2024 · Dec 31, 2024
Selling, General & Administrative
6.57B
NormalFY2024 · Dec 31, 2024
Other Operating Expenses
372.25M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Expense
2.01B
NormalFY2024 · Dec 31, 2024
EPS (Basic)
0.2500
NormalFY2024 · Dec 31, 2024
EPS (Diluted)
0.2500
NormalFY2024 · Dec 31, 2024
Basic Shares Outstanding
42.48BShares
NormalFY2024 · Dec 31, 2024
Diluted Shares Outstanding
42.48BShares
NormalFY2024 · Dec 31, 2024
Net Income from Continuing Operations
13.80B
NormalFY2024 · Dec 31, 2024
Minority Interests (P&L)
-523.45M
NormalFY2024 · Dec 31, 2024
Operating Cash Flow
11.36B
NormalFY2024 · Dec 31, 2024
Free Cash Flow
9.91B
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
14.12B
NormalFY2024 · Dec 31, 2024
Net Income (CF Statement)
13.80B
NormalFY2024 · Dec 31, 2024
Other Non-cash Items
-14.06B
NormalFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
11.62B
NormalFY2024 · Dec 31, 2024
Capital Expenditures
-361.38M
NormalFY2024 · Dec 31, 2024
Purchase of Investments
-312.62B
NormalFY2024 · Dec 31, 2024
Sale of Investments
282.80B
NormalFY2024 · Dec 31, 2024
Net Investing Cash Flow
-30.18B
NormalFY2024 · Dec 31, 2024
Long-term Debt Issuance
0.00
NormalFY2024 · Dec 31, 2024
Long-term Debt Payments
-1.43B
NormalFY2024 · Dec 31, 2024
Common Dividends Paid
-1.78B
NormalFY2024 · Dec 31, 2024
Other Financing Charges
10.40B
NormalFY2024 · Dec 31, 2024
Net Financing Cash Flow
7.19B
NormalFY2024 · Dec 31, 2024
Financial Strength20
Shares Outstanding
42.48BShares
NormalMar 18, 2026
Float Shares
6.24BHKD
NormalMar 18, 2026
% Held by Insiders
0.00HKD
NormalMar 18, 2026
% Held by Institutions
0.1790HKD
NormalMar 18, 2026
Total Cash (MRQ)
155.66BHKD
NormalMar 18, 2026
Total Cash per Share (MRQ)
3.23HKD
NormalMar 18, 2026
Total Debt (MRQ)
81.78BHKD
NormalMar 18, 2026
Total Debt to Equity (MRQ)
61.69HKD
ExtremeMar 18, 2026
Current Ratio (MRQ)
3.07HKD
AboveNormalMar 18, 2026
Book Value per Share (MRQ)
2.86HKD
NormalMar 18, 2026
Total Assets
508.35B
NormalFY2024 · Dec 31, 2024
Total Liabilities
395.68B
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents
7.29B
NormalFY2024 · Dec 31, 2024
Other Short-term Investments
151.02B
NormalFY2024 · Dec 31, 2024
Accounts Receivable
226.79M
NormalFY2024 · Dec 31, 2024
Accounts Payable
356.75M
NormalFY2024 · Dec 31, 2024
Long-term Debt
13.97B
NormalFY2024 · Dec 31, 2024
Common Stock (Book)
42.48B
NormalFY2024 · Dec 31, 2024
Retained Earnings
36.44B
NormalFY2024 · Dec 31, 2024
Total Shareholders' Equity
112.66B
NormalFY2024 · Dec 31, 2024
Market & Technical10
52-Week Low
0.7900HKD
NormalMar 18, 2026
52-Week High
1.84HKD
NormalMar 18, 2026
52-Week Change
34.66HKD
ExtremeMar 18, 2026
Beta
0.8740HKD
NormalMar 18, 2026
50-Day MA
1.68HKD
NormalMar 18, 2026
200-Day MA
1.54HKD
NormalMar 18, 2026
Avg 10-Day Volume
35.37MHKD
NormalMar 18, 2026
Avg 30-Day Volume
24.59MHKD
NormalMar 18, 2026
Diluted EPS (TTM)
0.3100HKD
NormalMar 18, 2026
Other Income / Expense
-94.30M
NormalFY2024 · Dec 31, 2024
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.